Search NLS News

The Novo Nordisk Foundation is committing up to USD 25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections. The three-year grant will go to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), a global non-profit public-private partnership in this space. The partnership plays a […]

Genovis’ CEO, Fredrik Olsson, received the award in a prize ceremony during SwedenBIO Summit at Grand Hôtel in Stockholm on 30th January. High-quality research, global presence and humor were some of the positive words describing the company Genovis, which claimed this year’s SwedenBIO Award. “Life science is a tough industry where success doesn’t come easy, […]

The company has reported positive topline results from the ongoing Part 3 of the CORIST phase IIa colorectal cancer trial with the lead compound SCO-101. A preliminary analysis of the study data shows tumor reduction supporting combination with chemotherapy, substantially increased Progression Free Survival, high Clinical Benefit Rate and consistent safety and tolerability, states the […]

Women’s health has been under-prioritized for a long time. It should be no surprise that women are approximately one half of the world’s population. Yet remarkably, only 1% of healthcare research and innovation is invested in specific female conditions outside oncology. At Medicon Valley Alliance we have decided to pick up the gauntlet and test the interest […]

The company has announced the primary analysis of study data from Alzinova’s phase 1b clinical trial in Alzheimer’s disease with the vaccine candidate ALZ-101. The analysis confirms the top-line results and that ALZ-101 was well tolerated and safe, states the company. Furthermore, the analysis confirms a high frequency of immune response and that patients treated […]

The Life Science Barometer is an annual survey with the aim of offering unique insights and fresh statistics about the Swedish life science industry. A record number of companies participated in the survey for this year’s edition, which makes the report SwedenBIO’s most comprehensive to date. The report is produced by SwedenBIO in collaboration with […]

Medical Devices Regulation Update: Exploring the Thriving Regulatory Landscape This year’s MedDev Day will focus on the attractiveness of the European regulatory landscape for medical devices, improvements made and future developments. The one-and-a-half-day program features Industry and competent authority talks followed by interactive workshops to allow elaborate solutions for post market programs and clinical strategy. Date: […]

The company has selected a TrkA-NAM drug candidate, ACD137, and started the preclinical development phase with the compound. “AlzeCure’s unique TrkA-NAM substances have extremely selective effects so that optimal pain-relieving effect is achievable without inducing side effects. As the TrkA-NAM substances are small molecules, they can be taken in tablet form, which makes it easier […]

The company has reported results from the OPTIMIZE-1 Phase 2 study of its lead asset mitazalimab in 1st line metastatic pancreatic cancer. The open-label, multi-center study assessed the safety and efficacy of mitazalimab (CD40 mAb agonist) in combination with standard of care chemotherapy mFOLFIRINOX, in previously untreated, chemotherapy naive patients. The study achieved its primary […]

Capitainer has announced the opening of its new US laboratory, miQro Lab Solutions, in Warwick, Rhode Island. This step reflects the company’s ambition to integrating its advanced self-sampling solutions into the U.S. healthcare system more rapidly, it states. Initially, the new miQro Lab Solutions laboratory will focus on clinical lab services, specializing in lead (Pb) […]